Showing results (341-350 of 491) with videos related to

Sort By:
Pageof 50
BMJ Open|November 30, 2019
Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)Mikkel Jürgens, Morten Schou, Philip Hasbak, et al.
Clinical Epidemiology|September 30, 2024
Excess Risk of Mortality and Hospitalization in Patients with Heart Failure According to Age and Comorbidity - A Nationwide Register StudyChristian Madelaire, Thomas Gerds, Lars Køber, et al.
European Journal of Heart Failure|December 20, 2016
The first-in-man randomized trial of a beta3 adrenoceptor agonist in chronic heart failure: the BEAT-HF trialHenning Bundgaard, Anna Axelsson, Jakob Hartvig Thomsen, et al.
European Journal of Heart Failure|April 5, 2020
Risk of heart failure in type 2 diabetes complicated by incident ischaemic heart disease and end-stage renal diseaseMariam E Malik, Christian Madelaire, Maria D'Souza, et al.
Heart Failure Reviews|October 7, 2022
Patients with fulminant myocarditis supported with veno-arterial extracorporeal membrane oxygenation: a systematic review and meta-analysis of short-term mortality and impact of risk factorsJulie K K Vishram-Nielsen, Farid Foroutan, Saima Rizwan, et al.
European Journal of Heart Failure|November 12, 2024
Long-term risk of heart failure in patients with postoperative atrial fibrillation following non-cardiac surgery: Insights from a nationwide cohortMunise N Karacan, Adelina Yafasova, Emil L Fosbøl, et al.
Trials|June 23, 2019
Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)Jesper Jensen, Massar Omar, Caroline Kistorp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2020
Measles, Mumps, Rubella, and Varicella Zoster Virus Serology and Infections in Solid Organ Transplant Recipients During the First Year PosttransplantationOmid Rezahosseini, Søren Schwartz Sørensen, Michael Perch, et al.
Diabetes, Obesity & Metabolism|December 9, 2022
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trialNiels H Brandt-Jacobsen, Mikkel Jürgens, Philip Hasbak, et al.
Cardiovascular Diabetology|January 29, 2026
Associations of body mass index on worsening of heart failure and mortality in patients with heart failure and reduced left ventricular ejection fraction: a 10-year follow-up study (a NorthStar substudy)Morten Malmborg, Mohamed El-Chouli, Camilla Fuchs Andersen, et al.
Pageof 50